Glutamate-Conjugated Liposomes of Dopamine Hydrochloride for Effective Management of Parkinsonism's

References

1. 1.↵
   1. Misra A.,
   2. Ganesh S.,
   3. Shahiwala A.

   Drug delivery to the central nervous system: a review. J. Pharm. Pharmaceut. Sci. 2003, 6 (2), 252–273

   OpenUrlPubMedWeb of Science
2. 2.↵
   1. Graff C. L.,
   2. Pollack G. M.

   Drug transport at the blood–brain barrier and the choroids plexus. Curr. Drug. Metab. 2004, 5 (1), 95–108

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Padridge W. M.

   Blood–brain barrier drug targeting: the future of brain drug development. Mol. Interv. 2003, 3 (2), 90–105

   OpenUrlCrossRefPubMed
4. 4.
   1. Begley D. J.

   The blood–brain barrier: principles for targeting peptides and drugs to the central nervous system. J. Pharm. Pharmacol. 1996, 48 (2), 136–146

   OpenUrlPubMed
5. 5.↵
   1. Schlossauer B.,
   2. Steuer H.

   Comparative anatomy, physiology and in vitro models of the blood–brain and blood–retina barrier. Current Medicinal Therapy—Central Nervous System Agents 2002, 2 (3), 175–186

   OpenUrl
6. 6.↵
   1. Tetsuya T.,
   2. Akaira T.

   Drug delivery to the brain utilizing blood brain barrier transport system. J. Controlled. Release 1994, 29 (1–2), 163–169

   OpenUrlCrossRef
7. 7.↵
   1. Pardridge W. M.

   Transport of small molecules through blood brain barrier biology and methodology. Adv. Drug Del. Rev. 1995, 15 (1–3), 5–36

   OpenUrlCrossRefWeb of Science
8. 8.↵
   1. Mixich F.

   The passage of liposomes through the blood brain barrier, ultra structural studies. J. Med. Biochem. 2000, 4, 106–110

   OpenUrl
9. 9.↵
   1. Pardridge W. M.

   Vector-mediated peptide drug delivery to the brain. Adv. Drug Del. Rev. 1995, 15 (1–3), 109–146

   OpenUrlCrossRefWeb of Science
10. 10.↵
    1. Smith Q. R.

    Carrier-mediated transport to enhance drug delivery to brain. Int. Congr. Ser. 2005, 1277, 63–74

    OpenUrl
11. 11.↵
    1. Collingridge G. L.,
    2. Lester R.

    Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 1989, 40 (2), 143–210

    OpenUrl
12. 12.↵
    1. Headley P. M.,
    2. Grillner S.

    Excitatory amino acids and synaptic transmission: the evidence for a physiological function. Trends Pharmacol. Sci. 1990, 11 (5), 205–211

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Vernadakis A.

    Glia–neuron intercommunications and synaptic plasticity. Prog. Neurobiol. 1996, 49 (3), 185–214

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Shelton M. K.,
    2. McCarthy K. D.

    Mature hippocampal astrocytes exhibit functional metabotropic and ionotropic glutamate receptors in situ. Glia 1999, 26 (1), 1–11

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Bergles D. E.,
    2. Roberts J. D.,
    3. Somogyi P.,
    4. Jahr C. E.

    Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 2000, 405 (6783), 187–191

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Hamberger A.,
    2. Nystrom B.

    Extra- and intracellular amino acids in the hippocampus during development of hepatic encephalopathy. Neurochem. Res. 1984, 9 (9), 1181–1192

    OpenUrlPubMed
17. 17.↵
    1. Ottersen O. P.,
    2. Laake J. H.,
    3. Reichelt W.,
    4. Haug F. M.,
    5. Torp R.

    Ischemic disruption of glutamate homeostasis in brain: quantitative immunocytochemical analysis. J. Chem. Neuroanat. 1996, 12 (1), 1–14

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Abraham A. M.,
    2. Walubo A.

    The effect of surface charge on the disposition of liposome encapsulated gentamicin to the rat liver, brain, lungs and kidney after intraperitoneal administration. Int. J. Antimicrob. Agents 2005, 25 (5), 392–397

    OpenUrlPubMed
19. 19.↵
    1. Schreier H.,
    2. Moran P.,
    3. Caras I. W.

    Targeting of liposomes to cells expressing CD4 using glycosylphosphatidyl inositol anchored Pgp 120. Influence of liposomes composition on intracellular trafficking. J. Biol. Chem. 1994, 269, 9090–9098

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Vyas S. P.,
    2. Singh A.,
    3. Sihorkar V.

    Ligand receptor mediated drug delivery: an emerging paradigm in cellular drug targeting. Cri. Rev. Ther. Drug Carrier Syst. 2001, 18 (1), 1–76

    OpenUrl
21. 21.↵
    1. Jain A.,
    2. Chourasia M. K.,
    3. Soni V.,
    4. Jain N. K.,
    5. Khare P.,
    6. Gupta Y.,
    7. Jain S. K.

    Brain specific drug delivery from lactyl stearate coupled liposomes via monocarboxylic acid transporters. Am. J. Drug Del. 2006, 4 (1), 43–49

    OpenUrl
22. 22.↵
    1. Gregoriadis G.,
    2. Florence A.

    T. Liposomes in drug delivery. Drugs 1993, 45, 15–28

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Huwyler J.,
    2. Wu D.,
    3. Pardridge M. W.

    Brain drug delivery of small molecules using immunoliposomes. Pro. Natl. Acad. Sci. USA 1996, 93 (24), 14164–14169

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Hermanson G. T.

    Bioconjugate Technique. 1996, 562 Academic Press, San Diego, California.
25. 25.↵
    1. Soni V. S.,
    2. Kohli D. V.,
    3. Jain S. K.

    Transferrin coupled liposomes as drug delivery carrier for brain targeting of 5-florouracil. J. Drug. Target. 2005, 13 (4), 245–250

    OpenUrlPubMed
26. 26.↵
    1. Bangham A. D.

    Membrane models with phospholipids. Prog. Biophy. Mol. Boil. 1968, 18, 29–39

    OpenUrl
27. 27.↵
    1. Fry D. W.,
    2. White J. C.,
    3. Goldman I. D.

    Rapid separation of low molecular weight solutes from liposomes without dilution. Anal. Biochem. 1978, 90 (2), 803–812

    OpenUrl
28. 28.↵
    United States Pharmacopoeia, 23; 1995; Asian Edition The United States Pharmacopoeial Convention, Inc.: Rockville, MD, p 549
29. 29.↵
    1. Jain N. K.,
    2. Rana A. C.,
    3. Jain S. K.

    Brain drug delivery system bearing Dopamine hydrochloride for effective management of Parkinsonism. Drug Dev. Indus. Pharm. 1998, 24 (7), 671–675

    OpenUrl
30. 30.↵
    1. Kullkarni S. K.

    Handbook of Experimental Pharmacology; 1990; Vallabh Prakashan: New Delhi, India p 72